What is a stock summary page? Click here for an overview.
Business Description
International Stem Cell Corp
NAICS : 325414
SIC : 2834
ISIN : US4603782016
Description
International Stem Cell Corp is a clinical-stage biotechnology company. It is focused on therapeutic and biomedical product development with multiple long-term therapeutic opportunities. The company develops different cell types from its stem cells that may result in therapeutic products. The clinical applications of the company include neural stem cells for the treatment of Parkinson's disease and other central nervous system disorders; Liver cells, which are used to treat a variety of congenital and acquired liver diseases; and retinal cells and three-dimensional eye structures. It operates in three segments, the therapeutic market, the biomedical market, and the anti-aging market. The Biomedical products business segment accounts for the majority of revenue.
Financial Strength
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.34 | |||||
| Equity-to-Asset | -0.78 | |||||
| Debt-to-Equity | -0.96 | |||||
| Debt-to-EBITDA | -11.46 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | -28.83 | |||||
| Beneish M-Score | -3.44 | |||||
| WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 1 | |||||
| 3-Year EPS without NRI Growth Rate | 35.7 | |||||
| 3-Year Book Growth Rate | 3 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 66.34 | |||||
| 9-Day RSI | 59.79 | |||||
| 14-Day RSI | 56.99 | |||||
| 3-1 Month Momentum % | 43.91 | |||||
| 6-1 Month Momentum % | 95 | |||||
| 12-1 Month Momentum % | 13.98 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.74 | |||||
| Quick Ratio | 0.45 | |||||
| Cash Ratio | 0.28 | |||||
| Days Inventory | 133.52 | |||||
| Days Sales Outstanding | 28.59 | |||||
| Days Payable | 34.62 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -2 | |||||
| Shareholder Yield % | 16.69 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 57.35 | |||||
| Operating Margin % | -6.37 | |||||
| Net Margin % | -7.95 | |||||
| FCF Margin % | 0.9 | |||||
| ROA % | -12.48 | |||||
| ROIC % | -9.35 | |||||
| 3-Year ROIIC % | 107.75 | |||||
| ROC (Joel Greenblatt) % | -29.44 | |||||
| ROCE % | -91.12 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.12 | |||||
| Price-to-Free-Cash-Flow | 12.25 | |||||
| Price-to-Operating-Cash-Flow | 3.95 | |||||
| EV-to-EBIT | -6.61 | |||||
| EV-to-EBITDA | -10.51 | |||||
| EV-to-Revenue | 0.42 | |||||
| EV-to-FCF | 46.16 | |||||
| Price-to-GF-Value | 0.72 | |||||
| Price-to-Median-PS-Value | 0.19 | |||||
| Earnings Yield (Greenblatt) % | -15.13 | |||||
| FCF Yield % | 7.85 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:ISCO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
International Stem Cell Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 8.528 | ||
| EPS (TTM) ($) | -0.08 | ||
| Beta | -0.01 | ||
| 3-Year Sharpe Ratio | -0.15 | ||
| 3-Year Sortino Ratio | -0.23 | ||
| Volatility % | 102.6 | ||
| 14-Day RSI | 56.99 | ||
| 14-Day ATR ($) | 0.008761 | ||
| 20-Day SMA ($) | 0.108873 | ||
| 12-1 Month Momentum % | 13.98 | ||
| 52-Week Range ($) | 0.0521 - 0.195 | ||
| Shares Outstanding (Mil) | 8 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
International Stem Cell Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
International Stem Cell Corp Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
International Stem Cell Corp Frequently Asked Questions
What is International Stem Cell Corp(ISCO)'s stock price today?
The current price of ISCO is $0.12. The 52 week high of ISCO is $0.20 and 52 week low is $0.05.
When is next earnings date of International Stem Cell Corp(ISCO)?
The next earnings date of International Stem Cell Corp(ISCO) is .
Does International Stem Cell Corp(ISCO) pay dividends? If so, how much?
International Stem Cell Corp(ISCO) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers